Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries With Atrial Fibrillation
- Resource Type
- Article
- Source
- In
The American Journal of Cardiology 1 July 2020 126:29-36 - Subject
- Language
- ISSN
- 0002-9149